Gyrate: CCM3 dances with a different angiogenic partner

Science Signaling

Volumn 3, Issue 122, 2010, Pages

  Dyer, Laura A ^a   Portbury, Andrea L ^a   Patterson, Cam ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN CEREBRAL CAVERNOUS MALFORMATION 3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTERY; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; REVIEW; VEIN;

ANIMALS; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77953827457     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.3122pe17     Document Type: Review

References (20)

1. J. Kessel, B. C. Fabian, Graded morphogenetic patterns during the development of the extraembryonic blood system and coelom of the chick blastoderm: A scanning electron microscope and light microscope study. Am. J. Anat. 173, 99-112 (1985).
2. K. Minko, K. Bollerot, C. Drevon, M. F. Hallais, T. Jaffredo, From mesoderm to blood islands: Patterns of key molecules during yolk sac erythropoiesis. Gene Expr. Patterns 3, 261-272 (2003).
3. C. Park, I. Afrikanova, Y. S. Chung, W. J. Zhang, E. Arentson, G. Fong Gh, A. Rosendahl, K. Choi, A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 131, 2749-2762 (2004).
4. S. Pearson, P. Sroczynska, G. Lacaud, V. Kouskoff, The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 135, 1525-1535 (2008).
5. M. Belaoussoff, S. M. Farrington, M. H. Baron, Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo. Development 125, 5009-5018 (1998).
6. N. Ferrara, H. Heinsohn, C. E. Walder, S. Bunting, G. R. Thomas, The regulation of blood vessel growth by vascular endothelial growth factor. Ann. N. Y. Acad. Sci. 752, 246-256 (1995).
7. F. Shalaby, J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman, A. C. Schuh, Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995).
8. F. Lanner, M. Sohl, F. Farnebo, Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation. Arterioscler. Thromb. Vasc. Biol. 27, 487-493 (2007).
9. N. D. Lawson, A. M. Vogel, B. M. Weinstein, sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3, 127-136 (2002).
10. C. A. Shaut, D. R. Keene, L. K. Sorensen, D. Y. Li, H. S. Stadler, M. Mullins, HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification. PLoS Genet. 4, e1000073 (2008).
11. L. R. You, F. J. Lin, C. T. Lee, F. J. DeMayo, M. J. Tsai, S. Y. Tsai, Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435, 98-104 (2005).
12. Y. He, H. Zhang, L. Yu, M. Gunel, T. J. Boggon, H. Chen, W. Min, Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci. Signal. 3, ra26 (2010).
13. F. Riant, F. Bergametti, X. Ayrignac, G. Boulday, E. Tournier-Lasserve, Recent insights into cerebral cavernous malformations: The molecular genetics of CCM. FEBS J. 277, 1070-1075 (2010).
14. M. Goudreault, L. M. D'Ambrosio, M. J. Kean, M. J. Mullin, B. G. Larsen, A. Sanchez, S. Chaudhry, G. I. Chen, F. Sicheri, A. I. Nesvizhskii, R. Aebersold, B. Raught, A. C. Gingras, A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol. Cell. Proteomics 8, 157-171 (2009).
15. L. Chen, G. Tanriover, H. Yano, R. Friedlander, A. Louvi, M. Gunel, Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3. Stroke 40, 1474-1481 (2009).
16. T. Abe, M. Morishige, H. Ooba, T. Kamida, M. Fujiki, H. Kobayashi, T. Sakoda, Y. Kimba, The association between high VEGF levels and multiple probable punctuate cavernous malformations. Acta Neurochir. (Wien) 151, 855-859 (2009).
17. K. H. Jung, K. Chu, S. W. Jeong, H. K. Park, H. J. Bae, B. W. Yoon, Cerebral cavernous malformations with dynamic and progressive course: Correlation study with vascular endothelial growth factor. Arch. Neurol. 60, 1613-1618 (2003).
18. X. Ma, H. Zhao, J. Shan, F. Long, Y. Chen, Y. Chen, Y. Zhang, X. Han, D. Ma, PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol. Biol. Cell 18, 1965-1978 (2007).
19. K. Voss, S. Stahl, B. M. Hogan, J. Reinders, E. Schleider, S. Schulte-Merker, U. Felbor, Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum. Mutat. 30, 1003-1011 (2009).
20. Funding: We thank NIH (grant 2RO1HL061656-11) for funding.